251 related articles for article (PubMed ID: 20089542)
21. Aspects of the cytological activity of edelfosine, miltefosine, and ilmofosine in Leishmania donovani.
Azzouz S; Maache M; Dos Santos MF; Sarciron ME; Petavy AF; Osuna A
J Parasitol; 2006 Oct; 92(5):877-83. PubMed ID: 17152926
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei brucei.
del Rayo Camacho M; Phillipson JD; Croft SL; Rock P; Marshall SJ; Schiff PL
Phytother Res; 2002 Aug; 16(5):432-6. PubMed ID: 12203262
[TBL] [Abstract][Full Text] [Related]
23. Leishmania donovani: pilot study for evaluation of therapeutic effects of inosine analogs against amastigotes in vitro and in vivo.
Morishige K; Aji T; Ishii A; Yasuda T; Wataya Y
Exp Parasitol; 1995 Jun; 80(4):665-71. PubMed ID: 7758547
[TBL] [Abstract][Full Text] [Related]
24. Leishmanicidal activity of edelfosine, miltefosine and ilmofosine.
Azzouz S; Maache M; Garcia RG; Osuna A
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):60-5. PubMed ID: 15667597
[TBL] [Abstract][Full Text] [Related]
25. In vitro anti-Leishmanial activity of compounds in current clinical use for unrelated diseases.
Neal RA; Allen S
Drugs Exp Clin Res; 1988; 14(10):621-8. PubMed ID: 3246207
[TBL] [Abstract][Full Text] [Related]
26. In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species.
de Morais-Teixeira E; Gallupo MK; Rodrigues LF; Romanha AJ; Rabello A
J Antimicrob Chemother; 2014 Jan; 69(1):150-4. PubMed ID: 23970484
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani.
Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM
Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140
[TBL] [Abstract][Full Text] [Related]
28. An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
Gebre-Hiwot A; Tadesse G; Croft SL; Frommel D
Acta Trop; 1992 Aug; 51(3-4):237-45. PubMed ID: 1359751
[TBL] [Abstract][Full Text] [Related]
29. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
Vermeersch M; da Luz RI; Toté K; Timmermans JP; Cos P; Maes L
Antimicrob Agents Chemother; 2009 Sep; 53(9):3855-9. PubMed ID: 19546361
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and anti-leishmanial activity of heterocyclic betulin derivatives.
Alakurtti S; Heiska T; Kiriazis A; Sacerdoti-Sierra N; Jaffe CL; Yli-Kauhaluoma J
Bioorg Med Chem; 2010 Feb; 18(4):1573-82. PubMed ID: 20116263
[TBL] [Abstract][Full Text] [Related]
31. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.
Kram D; Thäle C; Kolodziej H; Kiderlen AF
J Immunol Methods; 2008 Apr; 333(1-2):79-88. PubMed ID: 18313691
[TBL] [Abstract][Full Text] [Related]
32. Structure/antileishmanial activity relationship study of naphthoquinones and dependency of the mode of action on the substitution patterns.
Ali A; Assimopoulou AN; Papageorgiou VP; Kolodziej H
Planta Med; 2011 Dec; 77(18):2003-12. PubMed ID: 21800278
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions.
Ayres DC; Pinto LA; Giorgio S
J Parasitol; 2008 Dec; 94(6):1415-7. PubMed ID: 18576874
[TBL] [Abstract][Full Text] [Related]
34. Antileishmanial activity of nano-amphotericin B deoxycholate.
Manandhar KD; Yadav TP; Prajapati VK; Kumar S; Rai M; Dube A; Srivastava ON; Sundar S
J Antimicrob Chemother; 2008 Aug; 62(2):376-80. PubMed ID: 18453526
[TBL] [Abstract][Full Text] [Related]
35. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
Jamal Q; Khan NH; Wahid S; Awan MM; Sutherland C; Shah A
Exp Parasitol; 2015 Jul; 154():93-7. PubMed ID: 25911243
[TBL] [Abstract][Full Text] [Related]
36. Infectivity of five different types of macrophages by Leishmania infantum.
Maia C; Rolão N; Nunes M; Gonçalves L; Campino L
Acta Trop; 2007 Aug; 103(2):150-5. PubMed ID: 17626776
[TBL] [Abstract][Full Text] [Related]
37. Effect of allicin on promastigotes and intracellular amastigotes of Leishmania donovani and L. infantum.
Jesús Corral-Caridad M; Moreno I; Toraño A; Domínguez M; Alunda JM
Exp Parasitol; 2012 Dec; 132(4):475-82. PubMed ID: 22995646
[TBL] [Abstract][Full Text] [Related]
38. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India.
Singh SK; Bimal S; Narayan S; Jee C; Bimal D; Das P; Bimal R
Exp Parasitol; 2011 Feb; 127(2):552-8. PubMed ID: 21070771
[TBL] [Abstract][Full Text] [Related]
39. Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy.
Carter KC; Hutchison S; Boitelle A; Murray HW; Sundar S; Mullen AB
Parasitology; 2005 Dec; 131(Pt 6):747-57. PubMed ID: 16336728
[TBL] [Abstract][Full Text] [Related]
40. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages.
Channon JY; Roberts MB; Blackwell JM
Immunology; 1984 Oct; 53(2):345-55. PubMed ID: 6490087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
